CDER Deputy Director Gerald Meyer
This article was originally published in The Tan Sheet
Executive Summary
Will retire from FDA on Jan. 30, 1994 after 20 years at the agency. Meyer, 57, has been the second-in-command at the Center for Drug Evaluation and Research since 1986 and has helped steer the center through its first years of reorganization, including several reconfigurations of drug review divisions. The deputy director also was involved in the overhaul of CDER's generic drugs division in the aftermath of the generics scandal and the elevation of OTCs and generics to office status. Other changes at CDER management may be just beyond the horizon; Center Director Carl Peck, MD, is understood to be reevaluating his career plans.